ABRILADA
Pfizer Inc.
| Research |
OneLook
Acronym Finder
|
| Serial Number | 87482653 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Attorney Name | Richard A. Friedman |
| Attorney Docket Number | T421061 |
| Law Office Assigned | M40 |
| Employee Name | LEE, DOUGLAS M |
Timeline
| 2017-06-09 | Application Filed |
| 2018-04-03 | Published for Opposition |
| 2018-05-29 | Location: INTENT TO USE SECTION |
| 2019-11-25 | Status: Live/Pending |
| 2019-11-27 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Pfizer Inc. |
| Address | 235 East 42nd St. New York DE 10017 |
| Legal Entity Type | Corporation |
| Legal Entity State | DE |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations for use in hematology; pharmaceutical preparations, namely, anti-fungal preparations, dermatological preparations, smoking cessation preparations, and tissue repair preparations; vaccines for human use |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2017-06-13 | 1 NWAP I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2017-06-16 | 2 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2017-08-23 | 3 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2017-08-26 | 4 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2017-08-26 | 5 GNRT F:First Action |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2017-08-26 | 6 GNRN O:Outgoing Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2018-02-26 | 7 CNSA P: |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2018-03-14 | 8 NONP E:E-Mail |
| PUBLISHED FOR OPPOSITION | 2018-04-03 | 9 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2018-04-03 | 10 NPUB E:E-Mail |
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2018-05-29 | 11 NOAM E:E-Mail |
| TEAS EXTENSION RECEIVED | 2018-11-26 | 12 EEXT I:Incoming Correspondence |
| EXTENSION 1 FILED | 2018-11-26 | 13 EXT1 S: |
| EXTENSION 1 GRANTED | 2018-11-26 | 14 EX1G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2018-11-28 | 15 EXRA E:E-Mail |
| TEAS EXTENSION RECEIVED | 2019-05-22 | 16 EEXT I:Incoming Correspondence |
| EXTENSION 2 FILED | 2019-05-22 | 17 EXT2 S: |
| EXTENSION 2 GRANTED | 2019-05-22 | 18 EX2G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2019-05-24 | 19 EXRA E:E-Mail |
| TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | 2019-11-15 | 20 EWAF I:Incoming Correspondence |
| CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED | 2019-11-18 | 21 CHPB I:Incoming Correspondence |
| TEAS EXTENSION RECEIVED | 2019-11-25 | 22 EEXT I:Incoming Correspondence |
| EXTENSION 3 FILED | 2019-11-25 | 23 EXT3 S: |
| EXTENSION 3 GRANTED | 2019-11-25 | 24 EX3G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2019-11-27 | 25 EXRA E:E-Mail |
| TEAS EXTENSION RECEIVED | 2020-05-15 | 26 EEXT I:Incoming Correspondence |
| EXTENSION 4 FILED | 2020-05-15 | 27 EXT4 S: |
| EXTENSION 4 GRANTED | 2020-05-15 | 28 EX4G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2020-05-19 | 29 EXRA E:E-Mail |
| TEAS EXTENSION RECEIVED | 2020-10-26 | 30 EEXT I:Incoming Correspondence |
| CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2020-11-03 | 31 AITU A:Allowance for Publication |
| EXTENSION 5 FILED | 2020-10-26 | 32 EXT5 S: |
| EXTENSION 5 GRANTED | 2020-11-03 | 33 EX5G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2020-11-04 | 34 EXRA E:E-Mail |
| ABANDONMENT - NO USE STATEMENT FILED | 2021-07-05 | 35 ABN6 S: |
| ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | 2021-07-06 | 36 MAB6 E:E-Mail |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 ABRILADA 90229278 not registered Live/Pending |
Pfizer Inc. 2020-10-01 |
 ABRILADA 88907943 not registered Live/Pending |
Pfizer Inc. 2020-05-08 |
 ABRILADA 87482653 not registered Live/Pending |
Pfizer Inc. 2017-06-09 |
 ABRILADA 86578635 not registered Dead/Abandoned |
Pfizer Inc. 2015-03-27 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 